[HTML][HTML] Changing epidemiology, global trends and implications for outcomes of NAFLD
Non-alcoholic fatty liver disease (NAFLD) has rapidly become the most common liver
disease globally and is currently estimated to affect 38% of the global population. Only a …
disease globally and is currently estimated to affect 38% of the global population. Only a …
Epidemiology, pathogenesis, diagnosis and emerging treatment of nonalcoholic fatty liver disease
E Makri, A Goulas, SA Polyzos - Archives of medical research, 2021 - Elsevier
Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease, with an
estimated rising prevalence, in concert with the epidemics of obesity and type 2 diabetes …
estimated rising prevalence, in concert with the epidemics of obesity and type 2 diabetes …
The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease
Metabolic associated fatty liver disease (MAFLD) is the principal worldwide cause of liver
disease and affects nearly a quarter of the global population. The objective of this work was …
disease and affects nearly a quarter of the global population. The objective of this work was …
[HTML][HTML] Non-alcoholic fatty liver disease: A patient guideline
SM Francque, G Marchesini, A Kautz, M Walmsley… - JHEP reports, 2021 - Elsevier
This patient guideline is intended for all patients at risk of or living with non-alcoholic fatty
liver disease (NAFLD). NAFLD is the most frequent chronic liver disease worldwide and …
liver disease (NAFLD). NAFLD is the most frequent chronic liver disease worldwide and …
Resistant starch decreases intrahepatic triglycerides in patients with NAFLD via gut microbiome alterations
Y Ni, L Qian, SL Siliceo, X Long, E Nychas, Y Liu… - Cell Metabolism, 2023 - cell.com
Non-alcoholic fatty liver disease (NAFLD) is a hepatic manifestation of metabolic dysfunction
for which effective interventions are lacking. To investigate the effects of resistant starch (RS) …
for which effective interventions are lacking. To investigate the effects of resistant starch (RS) …
Risk assessment with gut microbiome and metabolite markers in NAFLD development
H Leung, X Long, Y Ni, L Qian, E Nychas… - Science translational …, 2022 - science.org
A growing body of evidence suggests interplay between the gut microbiota and the
pathogenesis of nonalcoholic fatty liver disease (NAFLD). However, the role of the gut …
pathogenesis of nonalcoholic fatty liver disease (NAFLD). However, the role of the gut …
Impact of the new definition of metabolic associated fatty liver disease on the epidemiology of the disease
Background & Aims Recently, a group of hepatologists proposed to rename non-alcoholic
fatty liver disease (NAFLD) as metabolic associated fatty liver disease (MAFLD) with …
fatty liver disease (NAFLD) as metabolic associated fatty liver disease (MAFLD) with …
Non-alcoholic fatty liver disease
Non-alcoholic fatty liver disease (NAFLD) has a global prevalence of 25% and is a leading
cause of cirrhosis and hepatocellular carcinoma. NAFLD encompasses a disease …
cause of cirrhosis and hepatocellular carcinoma. NAFLD encompasses a disease …
Noninvasive assessment of liver fibrosis in NAFLD
Nonalcoholic fatty liver disease (NAFLD) has emerged as a leading cause of liver-related
morbidity and mortality worldwide, afflicting approximately a billion individuals. NAFLD is a …
morbidity and mortality worldwide, afflicting approximately a billion individuals. NAFLD is a …
Mitochondrial dysfunction plays central role in nonalcoholic fatty liver disease
Nonalcoholic fatty liver disease (NAFLD) is a global pandemic that affects one-quarter of the
world's population. NAFLD includes a spectrum of progressive liver disease from steatosis to …
world's population. NAFLD includes a spectrum of progressive liver disease from steatosis to …